NCT03452878View on ClinicalTrials.gov

Evaluation of the Functional Results of Bilateral Amygdalotomy for Refractory Aggressive Patients

Active, not recruitingOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

August 6, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

December 31, 2026

Conditions
Aggression
Interventions
BEHAVIORAL

Aggressive behavior

Aggressive Behavior Scale, Quality of Life (SF-36) and Agitated Behavior Scale, measurement of thyroid-stimulating hormone (TSH), T4, T3, Cortisol, Luteinizing Hormone (LH), Estradiol, Prolactin, Progesterone, testosterone, and sex hormone-binding globulin (SHBG) and Resonance Magnetic Imaging.

All Listed Sponsors
lead

Hospital Sirio-Libanes

OTHER

NCT03452878 - Evaluation of the Functional Results of Bilateral Amygdalotomy for Refractory Aggressive Patients | Biotech Hunter | Biotech Hunter